NEW YORK (TheStreet) -- RATINGS CHANGES
Abbvie (ABBV) was upgraded to overweight from equal-weight. Twelve-month price target is $60. Company has an attractive pipeline and can generate healthy growth over the coming quarters, Morgan Stanley said.
Fortress Investment (FIG) was downgraded to hold at TheStreet Ratings.
FirstEnergy (FE) was upgraded at Jefferies to buy from hold. Valuation call with 12-month price target of $37, Jefferies said.GNC (GNC) was downgraded at Deutsche Bank to hold from buy. Twelve-month price target is $40. Company has a lackluster outlook for the remainder of the year, Deutsche Bank said. (HLT) was upgraded at Morgan Stanley to overweight. Twelve-month price target is $27. Company has strong fundamentals and there is upside for Waldorf Astoria valuation, Morgan Stanley said. Hilton was upgraded at MKM Partners to buy from neutral. Twelve-month price target is $27. Stock has underperformed, but has near-term catalysts, MKM Partners said. Infinity Pharmaceutical (INFI) was upgraded at Jefferies to buy from hold. Commerical competitiveness already priced in and risk/reward is attractive, Jefferies said. Twelve-month price target is $13. Buy rating. J.C. Penney (JCP - Get Report) was upgraded at UBS to neutral from sell. Less downside in SSS/GM risk for near term, UBS said. Twelve-month price target is $9. Intelligent Systems (INS) was downgraded to hold at TheStreet Ratings. Marriott (MAR) was downgraded at Morgan Stanley to equal-weight. Twelve-month price target is $64. Valuation call, as the stock has outperformed its peers by 14% year to date, Morgan Stanley said.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts